ABBV-243
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABBV-243, covering 2026-01-12 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults. [Phase 1]